Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H29N3O2 |
| Molecular Weight | 379.4953 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)[C@H]1CN(C)[C@@H]2CC3=CN(C(=O)CC)C4=C3C(=CC=C4)C2=C1
InChI
InChIKey=JSMQOVGXBIDBIE-OXQOHEQNSA-N
InChI=1S/C23H29N3O2/c1-5-21(27)26-14-15-12-20-18(17-9-8-10-19(26)22(15)17)11-16(13-24(20)4)23(28)25(6-2)7-3/h8-11,14,16,20H,5-7,12-13H2,1-4H3/t16-,20-/m1/s1
| Molecular Formula | C23H29N3O2 |
| Molecular Weight | 379.4953 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:45:02 GMT 2025
by
admin
on
Mon Mar 31 22:45:02 GMT 2025
|
| Record UNII |
23R2G2G79C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-1P-LSD
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
119025985
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
PRIMARY | |||
|
23R2G2G79C
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
PRIMARY | |||
|
1P-LSD
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
PRIMARY | 1P-LSD or 1-propionyl-lysergic acid diethylamide is a psychedelic drug of the lysergamide class that is an analog of LSD and homolog of ALD-52 and has been sold online as a designer drug.[1][2][3][4][5][6]While 1P-LSD shows only 38% the potency of LSD in mice, LSD is detected via LC-MS when 1P-LSD is incubated in human serum,[7] meaning 1P-LSD not only acts as a prodrug for LSD, but is also a directly acting serotonin receptor agonist in its own right. | ||
|
DTXSID701016895
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
PRIMARY | |||
|
2349358-81-0
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
PRIMARY | |||
|
300000001102
Created by
admin on Mon Mar 31 22:45:02 GMT 2025 , Edited by admin on Mon Mar 31 22:45:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->PARTIAL AGONIST |
Ki
|
||
|
|
TARGET->PARTIAL AGONIST |
Emax=11%
EC50
|
||
|
|
TARGET->PARTIAL AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
A recent intoxication case involving 1P-LSD indicated formation of LSD in vivo with no detection of the parent molecule.
|
